![D J Kim](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
D J Kim
Keine laufenden Positionen mehr
Karriereverlauf von D J Kim
Ehemalige bekannte Positionen von D J Kim
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Chemgenomics, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
REXAHN PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 | - |
Ausbildung von D J Kim
Seoul National University | Undergraduate Degree |
Korea Advanced Institute of Science & Technology | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Südkorea | 3 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Rexahn Pharmaceuticals, Inc.
![]() Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
Chemgenomics, Inc. |